Across TCGA pan-cancer cohorts, LINC01551 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01551’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC01551 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01551 is over-expressed in tumor, although a few such as THCA and HNSC show the opposite, repressed pattern.

COAD, THCA, and HNSC are the cancer types where LINC01551 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01551 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	+0.064	.029	4	view →
THCA	All	All	−0.037	.004	3	view →
HNSC	All	II,III,IV	−0.063	.032	2	view →
KICH	Male	All	−0.024	.030	2	view →
LUSC	All	All	+0.019	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LINC01551 RNA expression & survival · all LINC01551 data types